Recently, genomic analyses of 360 primary breast tumors showed that the core promoter of the NEAT1 gene is frequently mutated in cancer and most of these mutations are associated with loss of expression in in vitro assays38. The gene discussed is NEAT1; the disease is breast neoplasm.